Other research suggests that insulin-sensitizing agents, including thiazolidinediones (TZDs) such as pioglitazone, may be beneficial in the treatment of NAFLD [30]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.